{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:04:38Z","timestamp":1780455878089,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11655-026-4038-7","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:17:02Z","timestamp":1773659822000},"page":"545-552","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Taoren Honghua Jian Granule on NLRP3 Inflammasome Expression in Patients with Stable Coronary Artery Disease: A Multi-Center, Double-blind, Randomized Controlled Trial"],"prefix":"10.1007","volume":"32","author":[{"given":"Yi-ru","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-teng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-jiao","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le-yi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-rou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-di","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"4038_CR1","doi-asserted-by":"publisher","first-page":"7295","DOI":"10.3390\/ijms25137295","volume":"25","author":"E Mlynarska","year":"2024","unstructured":"Mlynarska E, Czarnik W, Fularski P, Hajdys J, Majchrowicz G, Stabrawa M, et al. From atherosclerotic plaque to myocardial infarction-the leading cause of coronary artery occlusion. Int J Mol Sci 2024;25:7295.","journal-title":"Int J Mol Sci"},{"key":"4038_CR2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41423-025-01284-9","volume":"22","author":"S Paik","year":"2025","unstructured":"Paik S, Kim JK, Shin HJ, Park EJ, Kim IS, Jo EK. Updated insights into the molecular networks for NLRP3 inflammasome activation. Cell Mol Immunol 2025;22:563\u2013596.","journal-title":"Cell Mol Immunol"},{"key":"4038_CR3","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41423-025-01284-9","volume":"22","author":"S Paik","year":"2025","unstructured":"Paik S, Kim JK, Shin HJ, Park EJ, Kim IS, Jo EK. Updated insights into the molecular networks for NLRP3 inflammasome activation. Cell Mol Immunol 2025;22:563\u2013596.","journal-title":"Cell Mol Immunol"},{"key":"4038_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jjcc.2024.03.003","volume":"84","author":"M Khair","year":"2024","unstructured":"Khair M, Khair M, Vangaveti VN, Malabu UH. The role of the NLRP3 inflammasome in atherosclerotic disease: systematic review and meta-analysis. J Cardiol 2024;84:14\u201321.","journal-title":"J Cardiol"},{"key":"4038_CR5","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","volume":"126","author":"A Abbate","year":"2020","unstructured":"Abbate A, Toldo S, Marchetti C, Kron J, Van Tassell BW, Dinarello CA. Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease. Circ Res 2020;126:1260\u20131280.","journal-title":"Circ Res"},{"key":"4038_CR6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tibtech.2022.11.008","volume":"41","author":"CYX Chua","year":"2023","unstructured":"Chua CYX, Jiang AY, Eufr\u00e1sio-da-Silva T, Dolatshahi-Pirouz A, Langer R, Orive G, et al. Emerging immunomodulatory strategies for cell therapeutics. Trends Biotechnol 2023;41:358\u2013373.","journal-title":"Trends Biotechnol"},{"key":"4038_CR7","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jacc.2023.04.003","volume":"82","author":"SS Virani","year":"2023","unstructured":"Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, et al. 2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on clinical practice guidelines. J Am Coll Cardiol 2023;82:833\u2013955.","journal-title":"J Am Coll Cardiol"},{"key":"4038_CR8","doi-asserted-by":"publisher","first-page":"154268","DOI":"10.1016\/j.phymed.2022.154268","volume":"104","author":"HY Yang","year":"2022","unstructured":"Yang HY, Liu ML, Luo P, Yao XS, Zhou H. Network pharmacology provides a systematic approach to understanding the treatment of ischemic heart diseases with traditional Chinese medicine. Phytomedicine 2022;104:154268.","journal-title":"Phytomedicine"},{"key":"4038_CR9","doi-asserted-by":"publisher","first-page":"16977","DOI":"10.1038\/s41598-024-67979-7","volume":"14","author":"Y Lu","year":"2024","unstructured":"Lu Y, Xue ZK, Gao W, Bai G, Zhang X, Chen KY, et al. Microcirculatory dysfunction in hypertrophic cardiomyopathy with chest pain assessed by angiography-derived microcirculatory resistance. Sci Rep 2024;14:16977.","journal-title":"Sci Rep"},{"key":"4038_CR10","doi-asserted-by":"publisher","first-page":"154684","DOI":"10.1016\/j.phymed.2023.154684","volume":"112","author":"X Feng","year":"2023","unstructured":"Feng X, Du M, Li S, Zhang Y, Ding J, Wang J, et al. Hydroxysafflor yellow A regulates lymphangiogenesis and inflammation via the inhibition of PI3K on regulating AKT\/mTOR and NF-\u03baB pathway in macrophages to reduce atherosclerosis in ApoE-\/- mice. Phytomedicine 2023;112:154684.","journal-title":"Phytomedicine"},{"key":"4038_CR11","doi-asserted-by":"publisher","first-page":"590929","DOI":"10.3389\/fphar.2020.590929","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang Y, Jia Q, Zhang Y, Wei J, Liu P. Amygdalin attenuates atherosclerosis and plays an anti-inflammatory role in ApoE knock-out mice and bone marrow-derived macrophages. Front Pharmacol 2020;11:590929.","journal-title":"Front Pharmacol"},{"key":"4038_CR12","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3390\/antiox14070883","volume":"14","author":"H Wang","year":"2025","unstructured":"Wang H, Dou X, Wang R, Jiang Y, Zhang J, Qiao X, et al. Salvianolic acid B alleviates LPS-induced spleen injury by remodeling redox status and suppressing NLRP3 inflammasome. Antioxidants (Basel) 2025;14:883.","journal-title":"Antioxidants (Basel)"},{"key":"4038_CR13","first-page":"396","volume":"13","author":"BQ Yin","year":"2021","unstructured":"Yin BQ, Guo YH, Liu Y, Zhao YY, Huang SM, Wei XW, et al. Molecular mechanism of Chuanxiong rhizoma in treating coronary artery diseases. Chin Herb Med 2021;13:396\u2013402.","journal-title":"Chin Herb Med"},{"key":"4038_CR14","doi-asserted-by":"publisher","first-page":"e17753","DOI":"10.1097\/MD.0000000000017753","volume":"98","author":"Y Wang","year":"2019","unstructured":"Wang Y, Zhang Y, Du Y, Yang Y, Wei J, Zhang N, et al. A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Taoren Honghua Jian granule in patients with stable coronary artery disease. Medicine (Baltimore) 2019;98:e17753.","journal-title":"Medicine (Baltimore)"},{"key":"4038_CR15","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","volume":"34","author":"G Montalescot","year":"2013","unstructured":"Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949\u20133003.","journal-title":"Eur Heart J"},{"key":"4038_CR16","volume-title":"Guiding principles for clinical research of new Chinese medicines","author":"XY Zheng","year":"2002","unstructured":"Zheng XY, ed. Guiding principles for clinical research of new Chinese medicines. Beijing: China Medical Science Press, 2002."},{"key":"4038_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ptr.8368","volume":"39","author":"J Pan","year":"2025","unstructured":"Pan J, Wang J, Lei Z, Wang H, Zeng N, Zou J, et al. Therapeutic Potential of Chinese Herbal Medicine and Underlying Mechanism for the Treatment of Myocardial Infarction. Phytother Res 2025;39:189\u2013232.","journal-title":"Phytother Res"},{"key":"4038_CR18","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic dsease. N Engl J Med 2017;377:1119\u20131131.","journal-title":"N Engl J Med"},{"key":"4038_CR19","first-page":"30","volume":"55","author":"C Xia","year":"2023","unstructured":"Xia, C, Yang, J, Hua, Y. Clinical study on Taoren Honghua Jian in treating stable angina of coronary heart disease with heart blood stasis syndrome. New Tradit Chin Med (Chin) 2023;55:30\u201333.","journal-title":"New Tradit Chin Med (Chin)"},{"key":"4038_CR20","doi-asserted-by":"publisher","first-page":"1504109","DOI":"10.3389\/fphar.2024.1504109","volume":"15","author":"J Chen","year":"2024","unstructured":"Chen J, Wu L, Xie X, Peng C. Carthamus tinctorius L. protects cerebral ischemia\/reperfusion injury via arachidonic acid\/p53-mediated apoptosis axis. Front Pharmacol 2024;15:1504109.","journal-title":"Front Pharmacol"},{"key":"4038_CR21","doi-asserted-by":"publisher","first-page":"1523176","DOI":"10.3389\/fphar.2025.1523176","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wu L, Wang H, Jiang M, Chen Y, Zheng X, et al. Ligusticum chuanxiong: a chemical, pharmacological and clinical review. Front Pharmacol 2025;16:1523176.","journal-title":"Front Pharmacol"},{"key":"4038_CR22","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3389\/fphar.2019.00753","volume":"10","author":"J Ren","year":"2019","unstructured":"Ren J, Fu L, Nile SH, Zhang J, Kai G. Salvia miltiorrhiza in treating cardiovascular diseases: a review on its pharmacological and clinical applications. Front Pharmacol 2019;10:753.","journal-title":"Front Pharmacol"},{"key":"4038_CR23","first-page":"1826","volume":"20","author":"J Zhu","year":"2019","unstructured":"Zhu J, Wu S, Hu S, Li H, Li M, Geng X, et al. NLRP3 inflammasome expression in peripheral blood monocytes of coronary heart disease patients and its modulation by rosuvastatin. Mol Med Rep 2019;20:1826\u20131836.","journal-title":"Mol Med Rep"},{"key":"4038_CR24","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.gendis.2023.01.009","volume":"11","author":"X Que","year":"2023","unstructured":"Que X, Zheng S, Song Q, Pei H, Zhang P. Fantastic voyage: the journey of NLRP3 inflammasome activation. Genes Dis 2023;11:819\u2013829.","journal-title":"Genes Dis"},{"key":"4038_CR25","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1161\/CIRCRESAHA.118.311362","volume":"122","author":"A Grebe","year":"2018","unstructured":"Grebe A, Hoss F, Latz E. NLRP3 inflammasome and the IL-1 pathway in atherosclerosis. Circ Res 2018;122:1722\u20131740.","journal-title":"Circ Res"},{"key":"4038_CR26","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","volume":"20","author":"O Soehnlein","year":"2021","unstructured":"Soehnlein O, Libby P. Targeting inflammation in atherosclerosis\u2014from experimental insights to the clinic. Nat Rev Drug Discov 2021;20:589\u2013610.","journal-title":"Nat Rev Drug Discov"},{"key":"4038_CR27","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/hc3901.096721","volume":"104","author":"Z Mallat","year":"2001","unstructured":"Mallat Z, Corbaz A, Scoazec A, Besnard S, Les\u00e8che G, Chvatchko Y, et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001;104:1598\u20131603.","journal-title":"Circulation"},{"key":"4038_CR28","doi-asserted-by":"publisher","first-page":"108053","DOI":"10.1016\/j.pharmthera.2021.108053","volume":"236","author":"S Toldo","year":"2022","unstructured":"Toldo S, Mezzaroma E, Buckley LF, Potere N, Di Nisio M, Biondi-Zoccai G, et al. Targeting the NLRP3 inflammasome in cardiovascular diseases. Pharmacol Ther 2022;236:108053.","journal-title":"Pharmacol Ther"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-4038-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-026-4038-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-4038-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:40:15Z","timestamp":1780454415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-026-4038-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4038"],"URL":"https:\/\/doi.org\/10.1007\/s11655-026-4038-7","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"12 November 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest, and there is no conflict of interest regarding the publication of this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}